Dilapan-S/Dilasoft E-Registry in Induction of Labor
Launched by MEDICEM INTERNATIONAL CR S.R.O. · Dec 11, 2014
Trial Information
Current as of May 14, 2025
Completed
Keywords
ClinConnect Summary
International Observational E-Registry to monitor current common clinical practice of use of Dilapan-S / Dilasoft for cervical ripening and following procedures of labour induction with the main focus on the duration of induced labor procedure .
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Indication for induction of labor
- • Unfavourable cervix
- Exclusion Criteria:
- • Presence of overt genital tract infection
About Medicem International Cr S.R.O.
Medicem International CR s.r.o. is a leading clinical trial sponsor specializing in the development and management of innovative therapies across various therapeutic areas. With a commitment to advancing healthcare through rigorous scientific research, Medicem International CR s.r.o. collaborates with healthcare professionals and regulatory bodies to ensure the highest standards of patient safety and data integrity. The organization leverages its extensive expertise in clinical operations and regulatory compliance to facilitate the efficient conduct of clinical trials, ultimately aiming to bring novel treatments to market that improve patient outcomes and enhance the quality of life.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Berlin, , Germany
New York, New York, United States
Galveston, Texas, United States
Brno, , Czechia
Frankfurt Am Main, , Germany
New Delhi, Delhi, India
Chennai, Tamil Nadu, India
Hyderabad, Telangana, India
Moscow, , Russian Federation
Trnava, , Slovakia
Birmingham, West Midlands, United Kingdom
Patients applied
Trial Officials
Lars Hellmeyer, Doz, MD
Principal Investigator
Vivantes Klinikum im Friedrichshain, Berlin, Germany
Franz Bahlman, Doz, MD
Principal Investigator
Buerger Hospital, Frankfurt am Main, Germany
Janesh Gupta, MD, FRCOG
Study Chair
Birmingham Women´s Hospital, Birmingham, UK
Petr Janku, MD
Principal Investigator
Masaryk University Hospital, Brno, Czech Republic
Jozef Zahumensky, Doc, MD
Principal Investigator
University Hospital, Trnava, Slovakia
Oleg Baev, MD, PhD
Principal Investigator
Federal State Budget Institution "Research Center for Obstetrics, Gynecology and Perinatology" of the Ministry of Healthcare of Russian Federation, Moscow, RUS
Antonio Saad, MD, PhD
Principal Investigator
University of Texas Medical Branch Galveston, TX, US
Amitasrigowri Murthy, MD, PhD
Principal Investigator
Bellevue Hospital, New York City, NY, US
Amita Suneja, Prof, MD
Principal Investigator
Guru Teg Bahadur Hospital, New Delhi, India
Usha Vishwanath, MD
Principal Investigator
Sri Ramachandra Medical Center, Chennai, India
Anisha Gala, MD
Principal Investigator
Fernandez Hospital, Hyderabad, India
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials